Digestive duplication cyst of the tongue

Summary

Digestive duplication cyst of the tongue (MONDO:0015384) is a disease. A subtype of tongue disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	digestive duplication cyst of the tongue
Mondo ID	MONDO:0015384
Orphanet	141071
UMLS	C4512051
MedGen	1393450
GARD	0019942
Anatomy (UBERON)	UBERON:0001723
Is cancer (heuristic)	no

Also known as: cysts and fistulae of the face and oral cavity of tongue · enteric duplication cyst of the tongue · foregut duplication cyst of the tongue · gastric duplication cyst of the tongue · tongue cysts and fistulae of the face and oral cavity

Disease family

This is a subtype of tongue disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › mouth disorder › tongue disorder › digestive duplication cyst of the tongue

Related subtypes (8): hypertrophy of tongue papillae, glossitis, hairy tongue, ankyloglossia, fissured tongue, isolated congenital hypoglossia/aglossia, tongue neoplasm, glossodynia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.